Fighting Fire with Fire: A Patent for the Combined Application of Oncolytic Herpes Viruses and Antiangiogenic Agents in the Battle Against Human Cancers
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
10
Page:
176-181
Author(s):
Matthias Karrasch and Christoph Rehfuess
Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent
Journal:
Current Topics in Medicinal Chemistry
Volume:
15
Page:
1409-1422
Author(s):
Suzanne M. Cutts, Ada Rephaeli, Abraham Nudelman, Michal Ugarenko and Don R. Phillips
Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression
Journal:
Current Topics in Medicinal Chemistry
Volume:
15
Page:
1323-1358
Author(s):
Mohamed Amine Bouhlel, Melanie Lambert and Marie-Helene David-Cordonnier
Therapeutic Agents Based on DNA Sequence Specific Binding
Journal:
Current Topics in Medicinal Chemistry
Volume:
15
Page:
1293-1322
Author(s):
Luke Pett, John A. Hartley and Konstantinos Kiakos
LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
10
Page:
170-175
Author(s):
Baichuan Li, Songshen Cao and Yunlai Liu
Vinyl Azides as Versatile Synthons for the Synthesis of Nitrogen-containing Heterocycles
Journal:
Current Organic Chemistry
Volume:
19
Page:
776-789
Author(s):
Hangcheng Ni, Guolin Zhang and Yongping Yu
The N-Terminal Region of HIV-1 Tat Protein Binds CD127 in Human CD8 T Cells to Target the Receptor for Down Regulation Through Tat's Basic Region
Journal:
Current HIV Research
Volume:
13
Page:
226-243
Author(s):
Scott M. Sugden and Paul A. MacPherson
Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
Journal:
Clinical Cancer Drugs
Volume:
2
Page:
61-70
Author(s):
Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger
Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma
Journal:
Clinical Cancer Drugs
Volume:
2
Page:
44-53
Author(s):
Karen E. Thudium, Lance Wollenberg, Cory Mavis, Jenny Gu, Gerald J. Fetterly, Myron S. Czuczman and Francisco J. Hernandez-Ilizaliturri
Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
Journal:
Current Cancer Drug Targets
Volume:
15
Page:
196-204
Author(s):
Wei Li, Xiao-Le Zhao, Shi-Qiang Shang, Hong-Qiang Shen and Xi Chen